STOCK TITAN

Insider of MAZE (NASDAQ: MAZE) files to sell 74,853 shares via option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

MAZE files a Form 144 to sell 74,853 shares of Common Stock via exercise of stock options on 03/10/2026. The filing lists prior 10b5-1 dispositions by Harold Bernstein, including sales of 45,000 shares on 12/29/2025 and 25,156 shares on 01/07/2026

The notice states the method as cash proceeds from the option exercise; timing and final cash‑flow details follow the exercise on 03/10/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies a planned sale of 74,853 shares by an affiliate via option exercise.

The filing records an intended disposition of 74,853 Common shares on 03/10/2026 through exercise of stock options for cash. It also lists multiple prior 10b5-1 sales by Harold Bernstein, with notable amounts of 45,000 and 25,156 shares on 12/29/2025 and 01/07/2026.

These entries are routine compliance notices that disclose planned insider sales; cash‑flow treatment is described as cash from exercise. Subsequent filings will show actual proceeds and any post‑transaction holdings.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does MAZE's Form 144 filing report?

The filing reports a proposed sale of 74,853 Common shares by exercise of stock options on 03/10/2026. It lists the method as cash proceeds from the exercise and includes prior 10b5-1 sales by Harold Bernstein.

Who is associated with the past 10b5-1 sales listed in the MAZE filing?

The past sales are attributed to Harold Bernstein, showing multiple 10b5-1 dispositions. Examples include 45,000 shares on 12/29/2025 and 25,156 shares on 01/07/2026

How will MAZE receive proceeds from the reported transaction?

The filing indicates the shares are being sold through exercise of stock options for cash on 03/10/2026. The document ties the method to cash proceeds; exact dollar proceeds from the exercise will appear in subsequent transaction reporting.

Does the Form 144 disclose the total cash value of the planned sale?

The notice specifies 74,853 shares to be sold by exercise on 03/10/2026 and lists prior sale dollar amounts. It does not present a single aggregated cash total for the planned exercise within the provided excerpt.
Maze Therapeutics

NASDAQ:MAZE

View MAZE Stock Overview

MAZE Rankings

MAZE Latest News

MAZE Latest SEC Filings

MAZE Stock Data

2.42B
42.04M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SOUTH SAN FRANCISCO